NRG
CVS icon

Nemes Rush Group’s CVS Health CVS Stock Holding History

Nemes Rush Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$131K Buy
1,828
+106
+6% +$8.17K 0.01% 251
2025
Q4 		$137K Buy
1,722
+82
+5% +$6.46K 0.01% 239
2025
Q3 		$124K Sell
1,640
-100
-6% -$6.85K 0.01% 241
2025
Q2 		$120K Sell
1,740
-7
-0.4% -$459 0.01% 239
2025
Q1 		$118K Hold
1,747
– – 0.01% 242
2024
Q4 		$78.4K Sell
1,747
-7
-0.4% -$393 0.01% 265
2024
Q3 		$140K Buy
1,754
+7
+0.4% +$408 0.02% 183
2024
Q2 		$103K Sell
1,747
-157
-8% -$9.82K 0.01% 222
2024
Q1 		$152K Buy
1,904
+115
+6% +$8.78K 0.02% 181
2023
Q4 		$141K Sell
1,789
-135
-7% -$9.61K 0.02% 188
2023
Q3 		$134K Sell
1,924
-75
-4% -$5.31K 0.02% 187
2023
Q2 		$138K Buy
+1,999
New +$142K 0.02% 192

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Nemes Rush Group's CVS Position: Q1 2026 in Review

Nemes Rush Group increased its CVS Health (CVS) stake by 6.2% in Q1 2026, buying an estimated $8.17K and bringing the position to 1,828 shares worth $131K. The position accounts for 0.01% of the portfolio, ranked #251.

Nemes Rush Group first reported a position in CVS in Q2 2023 and has held it in 12 quarters since. The position peaked at $152K in Q1 2024. 1,867 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Nemes Rush Group held 1,828 shares of CVS Health worth $131K as of Q1 2026.
  • Nemes Rush Group bought 106 CVS Health shares in Q1 2026, an estimated $8.17K.
  • CVS Health made up 0.01% of Nemes Rush Group's portfolio in Q1 2026, its #251 holding.
  • Nemes Rush Group first reported a position in CVS Health in Q2 2023 and has held it in 12 quarters since.
  • Nemes Rush Group's CVS Health position peaked at $152K in Q1 2024.
  • 1,867 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Nemes Rush Group's 13F filing for Q1 2026, filed 21 Apr 2026.